Introduction. Uterine fibroids are the most common benign tumor in women of reproductive age. By age 50, this pathology is diagnosed in 70 % of women, but only a quarter of them develop clinically significant symptoms. Giant fibroids (10–18 % of cases) deserve special attention, as they are accompanied by severe symptoms: chronic bleeding, anemia, and compression of adjacent organs, which significantly impairs quality of life and requires complex surgical treatment. The purpose of the study: To present a clinical case of symptomatic giant uterine fibroids, demonstrating diagnostic features and surgical approach. Research methodology: We analyzed the patient's medical history, clinical presentation, laboratory and instrumental examinations (ultrasound, MRI with contrast), and described treatment strategies taking into account the specific size of the tumor. Results: Patient P., 55, with a normal menstrual cycle, was hospitalized with complaints of a large abdominal mass and heavy menstrual flow. Examination revealed a giant uterine myoma measuring up to 25 cm (equivalent to 35–36 weeks of pregnancy), complicated by hemorrhagic syndrome with the development of anemia (hemoglobin 101 g/L) and compression of the ureters with bilateral hydroureteronephrosis. Following a consultation with a specialist from the Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatal Medicine, a decision was made to perform surgical treatment consisting of a midline laparotomy and extirpation of the uterus and appendages. The weight of the removed macrospecimen was 4115 g. Histological examination confirmed an intramural leiomyoma with degenerative changes and also revealed associated pathology: endometrial hyperplasia, chronic endometritis, and adenomyosis. The postoperative period was uneventful, and the patient was discharged on the seventh day in satisfactory condition. Conclusion: This clinical case demonstrates the unfavorable course of myomatous disease in the absence of timely follow-up. The enormous size of the tumor led to the development of multiorgan complications, requiring radical surgical intervention. This observation highlights the need for regular gynecological monitoring in perimenopausal women to ensure the timely detection and treatment of uterine myomas and prevent life-threatening complications.